Patent · US Active

Inhibitors and their uses

US11154519B2 · kind B2 · utility

0Cited by
2References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 8, 2016
Grant dateOct 26, 2021
Priority date
Expiry dateApr 8, 2036

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/916
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention relates to inhibitors of PPP1 R15A and PPP1 R15B and their use in therapy, particularly in the treatment of a disease state alleviated by the inhibition of PPP1 R15A and PPP1 R15B, for example a disorder associated with accumulation of misfolded proteins or proteostatsis disorder. Compounds of the invention include compounds having the formula IA or a pharmaceutically acceptable salt thereof, wherein R1a, R3a, R5a, Xa and Ya are as defined herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.